Tolerability of once-weekly alendronate in Patients with osteoporosis: A randomized, double-blind, placebo-controlled study
- Author
- GREENSPAN, Susan1 ; FIELD-MUNVES, Ellen2 ; TONINO, Richard3 ; SMITH, Mary4 ; PETRUSCHKE, Richard4 ; LIXIA WANG4 ; YATES, John4 ; DE PAPP, Anne E4 ; PALMISANO, Joanne4
[1] Osteoporosis Prevention & Treatment Center, Pittsburgh, Pa, United States
[2] Gateway Professional Center, Bethlehem, Pa, United States
[3] Good Health P.C., South Burlington, Vt, United States
[4] Merck & Co, Inc, West Point, Pa, United States - Source
Mayo Clinic proceedings. 2002, Vol 77, Num 10, pp 1044-1052 ; ref : 31 ref
- CODEN
- MACPAJ
- ISSN
- 0025-6196
- Scientific domain
- General medicine general surgery
- Publisher
- Mayo Medical Ventures, Rochester, MN
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Acide alendronique Bisphosphonates Chimiothérapie Diphosphonique acide dérivé Duodénum pathologie Estomac pathologie Forme libération contrôlée Forme pharmaceutique Homme Oesophage pathologie Ostéoporose Toxicité Traitement Appareil digestif pathologie Ostéopathie Système ostéoarticulaire pathologie
- Keyword (en)
- Alendronic acid Bisphosphonates Chemotherapy Diphosphonic acid derivatives Duodenal disease Gastric disease Controlled release form Dosage form Human Esophageal disease Osteoporosis Toxicity Treatment Digestive diseases Bone disease Diseases of the osteoarticular system
- Keyword (es)
- Acido alendrónico Bisfosfonatos Quimioterapia Difosfonico ácido derivado Duodeno patología Estómago patología Forma liberación controlada Forma farmacéutica Hombre Esófago patología Osteoporosis Toxicidad Tratamiento Aparato digestivo patología Osteopatía Sistema osteoarticular patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02U Drug toxicity and drugs side effects treatment / 002B02U04 Toxicity: digestive system
- Discipline
- Drugs toxicity and drug intoxications Toxicology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 13959327
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.4065/77.10.1044 
https://dx.doi.org/10.4065/77.10.1044
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.4065\/77.10.1044\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Tolerability of once-weekly alendronate in Patients with osteoporosis: A randomized, double-blind, placebo-controlled study\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Mayo Clinic proceedings\";s:9:\"\u0000*\u0000stitle\";s:15:\"Mayo Clin. proc\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"77\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1044\";s:8:\"\u0000*\u0000epage\";s:4:\"1052\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0025-6196\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"GREENSPAN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Susan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:19:\"FIELD-MUNVES, Ellen\";i:1;s:15:\"TONINO, Richard\";i:2;s:11:\"SMITH, Mary\";i:3;s:19:\"PETRUSCHKE, Richard\";i:4;s:10:\"LIXIA WANG\";i:5;s:11:\"YATES, John\";i:6;s:15:\"DE PAPP, Anne E\";i:7;s:17:\"PALMISANO, Joanne\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"MACPAJ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Tolerability of once-weekly alendronate in Patients with osteoporosis: A randomized, double-blind, placebo-controlled study\";s:8:\"\u0000*\u0000place\";s:13:\"Rochester, MN\";s:6:\"\u0000*\u0000pub\";s:21:\"Mayo Medical Ventures\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.4065\/77.10.1044\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Tolerability of once-weekly alendronate in Patients with osteoporosis: A randomized, double-blind, placebo-controlled study\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Mayo Clinic proceedings\";s:9:\"\u0000*\u0000stitle\";s:15:\"Mayo Clin. proc\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"77\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1044\";s:8:\"\u0000*\u0000epage\";s:4:\"1052\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0025-6196\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"GREENSPAN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Susan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:19:\"FIELD-MUNVES, Ellen\";i:1;s:15:\"TONINO, Richard\";i:2;s:11:\"SMITH, Mary\";i:3;s:19:\"PETRUSCHKE, Richard\";i:4;s:10:\"LIXIA WANG\";i:5;s:11:\"YATES, John\";i:6;s:15:\"DE PAPP, Anne E\";i:7;s:17:\"PALMISANO, Joanne\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"MACPAJ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Tolerability of once-weekly alendronate in Patients with osteoporosis: A randomized, double-blind, placebo-controlled study\";s:8:\"\u0000*\u0000place\";s:13:\"Rochester, MN\";s:6:\"\u0000*\u0000pub\";s:21:\"Mayo Medical Ventures\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:18:\"10.4065\/77.10.1044\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.4065\/77.10.1044\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Tolerability of once-weekly alendronate in Patients with osteoporosis: A randomized, double-blind, placebo-controlled study\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Mayo Clinic proceedings\";s:9:\"\u0000*\u0000stitle\";s:15:\"Mayo Clin. proc\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"77\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1044\";s:8:\"\u0000*\u0000epage\";s:4:\"1052\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0025-6196\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"GREENSPAN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Susan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:19:\"FIELD-MUNVES, Ellen\";i:1;s:15:\"TONINO, Richard\";i:2;s:11:\"SMITH, Mary\";i:3;s:19:\"PETRUSCHKE, Richard\";i:4;s:10:\"LIXIA WANG\";i:5;s:11:\"YATES, John\";i:6;s:15:\"DE PAPP, Anne E\";i:7;s:17:\"PALMISANO, Joanne\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"MACPAJ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Tolerability of once-weekly alendronate in Patients with osteoporosis: A randomized, double-blind, placebo-controlled study\";s:8:\"\u0000*\u0000place\";s:13:\"Rochester, MN\";s:6:\"\u0000*\u0000pub\";s:21:\"Mayo Medical Ventures\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.4065\/77.10.1044\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Tolerability of once-weekly alendronate in Patients with osteoporosis: A randomized, double-blind, placebo-controlled study\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Mayo Clinic proceedings\";s:9:\"\u0000*\u0000stitle\";s:15:\"Mayo Clin. proc\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"77\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1044\";s:8:\"\u0000*\u0000epage\";s:4:\"1052\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0025-6196\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"GREENSPAN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Susan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:19:\"FIELD-MUNVES, Ellen\";i:1;s:15:\"TONINO, Richard\";i:2;s:11:\"SMITH, Mary\";i:3;s:19:\"PETRUSCHKE, Richard\";i:4;s:10:\"LIXIA WANG\";i:5;s:11:\"YATES, John\";i:6;s:15:\"DE PAPP, Anne E\";i:7;s:17:\"PALMISANO, Joanne\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"MACPAJ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Tolerability of once-weekly alendronate in Patients with osteoporosis: A randomized, double-blind, placebo-controlled study\";s:8:\"\u0000*\u0000place\";s:13:\"Rochester, MN\";s:6:\"\u0000*\u0000pub\";s:21:\"Mayo Medical Ventures\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.4065\/77.10.1044\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Tolerability of once-weekly alendronate in Patients with osteoporosis: A randomized, double-blind, placebo-controlled study\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Mayo Clinic proceedings\";s:9:\"\u0000*\u0000stitle\";s:15:\"Mayo Clin. proc\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"77\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1044\";s:8:\"\u0000*\u0000epage\";s:4:\"1052\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0025-6196\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"GREENSPAN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Susan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:19:\"FIELD-MUNVES, Ellen\";i:1;s:15:\"TONINO, Richard\";i:2;s:11:\"SMITH, Mary\";i:3;s:19:\"PETRUSCHKE, Richard\";i:4;s:10:\"LIXIA WANG\";i:5;s:11:\"YATES, John\";i:6;s:15:\"DE PAPP, Anne E\";i:7;s:17:\"PALMISANO, Joanne\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"MACPAJ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Tolerability of once-weekly alendronate in Patients with osteoporosis: A randomized, double-blind, placebo-controlled study\";s:8:\"\u0000*\u0000place\";s:13:\"Rochester, MN\";s:6:\"\u0000*\u0000pub\";s:21:\"Mayo Medical Ventures\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
